Jump to content
RemedySpot.com

RESEARCH - Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with RA

Rate this topic


Guest guest

Recommended Posts

Guest guest

Ann Rheum Dis. Published Online First: 3 August 2008.

doi:10.1136/ard.2008.095596

--------------------------------------------------------------------------------

Concise Report

Associations of obesity with modifiable risk factors for the

development of cardiovascular disease in patients with rheumatoid

arthritis

s Stavropoulos-Kalinoglou 1*, Giorgos S Metsios 1, Vasileios F

Panoulas 2, M J 3, Alan M Nevill 1, Athanasios Z

Jamurtas 4, Marina Kita 3, Yiannis Koutedakis 4 and D Kitas 3

1 University of Wolverhampton, United Kingdom

2 s Hall Hospital, Dudley Group of Hospitals, NHS Trust, United Kingdom

3 Dudley Group of Hospitals, United Kingdom

4 Univeristy of Thessaly, Greece

Abstract

Objectives: To assess the associations of body mass index (BMI) with

modifiable cardiovascular disease (CVD) risk factors in patients with

rheumatoid arthritis (RA).

Methods: BMI, disease activity, selected CVD risk factors and CVD

medication were assessed in 378 (276 females) RA patients. Patients

exceeding accepted thresholds in 3 CVD risk factors were classified as

having the metabolic syndrome (MetS).

Results: BMI independently associated with hypertension (OR=1.28 (95%

CI=1.22-1.34); p=0.001), HDL (OR=1.10 (1.06-1.15); p=0.025), insulin

resistance (OR= 1.13 (1.08-1.18); p=0.000) and the MetS (OR=1.15

(1.08-1.21); p=0.000). In multivariable analyses, BMI had the

strongest associations with CVD risk factors (F1-354=8.663, p=0.000),

and was followed by lipid-lowering treatment (F1-354=7.651, p=0.000),

age (F1-354=7.541, p=0.000), antihypertensive treatment (F1-354=4.997,

p=0.000) and gender (F1-354=4.707, p=0.000). Prevalence of

hypertension (p=0.004), insulin resistance (p=0.005) and the MetS

(p=0.000) was significantly different between normal, overweight and

obese RA patients, and BMI differed significantly according to the

number of risk factors present (p=0.000).

Conclusions: Increasing BMI associates with increased CVD risk

independently of many confounders. RA-specific BMI cut-off points

better identify RA patients at increased CVD risk. Weight-loss regimes

should be developed and applied in order to reduce CVD in RA patients.

http://ard.bmj.com/cgi/content/abstract/ard.2008.095596v1?papetoc

--

Not an MD

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...